90 related articles for article (PubMed ID: 15533297)
41. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection.
Arinola OG; Louis JS; Tacchini-Cottier F; Aseffa A; Salimonu LS
Afr J Med Med Sci; 2005 Mar; 34(1):65-70. PubMed ID: 15971557
[TBL] [Abstract][Full Text] [Related]
42. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
[TBL] [Abstract][Full Text] [Related]
43. The effect of halofuginone, Wellcome 993 C, oxytetracycline, and diminazene diaceturate on Babesia equi-infected lymphoblastoid cell cultures.
Zweygarth E; Ahmed JS; Rehbein G
J Parasitol; 1984 Aug; 70(4):542-4. PubMed ID: 6502356
[TBL] [Abstract][Full Text] [Related]
44. In vivo and in vitro control of Leishmania mexicana due to garlic-induced NO production.
Gamboa-León MR; Aranda-González I; Mut-Martín M; García-Miss MR; Dumonteil E
Scand J Immunol; 2007 Nov; 66(5):508-14. PubMed ID: 17953527
[TBL] [Abstract][Full Text] [Related]
45. Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity.
Bhattacharjee S; Gupta G; Bhattacharya P; Mukherjee A; Mujumdar SB; Pal A; Majumdar S
J Antimicrob Chemother; 2009 Feb; 63(2):317-24. PubMed ID: 19036753
[TBL] [Abstract][Full Text] [Related]
46. Antileishmanial activity of Eugenol-rich essential oil from Ocimum gratissimum.
Ueda-Nakamura T; Mendonça-Filho RR; Morgado-Díaz JA; Korehisa Maza P; Prado Dias Filho B; Aparício Garcia Cortez D; Alviano DS; Rosa Mdo S; Lopes AH; Alviano CS; Nakamura CV
Parasitol Int; 2006 Jun; 55(2):99-105. PubMed ID: 16343984
[TBL] [Abstract][Full Text] [Related]
47. The influence of glutathione modulators on the course of Leishmania major infection in susceptible and resistant mice.
Cruz KK; Fonseca SG; Monteiro MC; Silva OS; Andrade VM; Cunha FQ; Romão PR
Parasite Immunol; 2008 Mar; 30(3):171-4. PubMed ID: 18251971
[TBL] [Abstract][Full Text] [Related]
48. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes.
Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN
Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660
[TBL] [Abstract][Full Text] [Related]
49. [Efficacy of a kaurenic acid extracted from the Venezuelan plant Wedelia trilobata (Asteracea) against Leishmania (Viannia) braziliensis].
Brito S; Crescente O; Fernández A; Coronado A; Rodriguez N
Biomedica; 2006 Oct; 26 Suppl 1():180-7. PubMed ID: 17361853
[TBL] [Abstract][Full Text] [Related]
50. The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine.
Yardley V; Croft SL; De Doncker S; Dujardin JC; Koirala S; Rijal S; Miranda C; Llanos-Cuentas A; Chappuis F
Am J Trop Med Hyg; 2005 Aug; 73(2):272-5. PubMed ID: 16103588
[TBL] [Abstract][Full Text] [Related]
51. In vitro activity of C20-diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum.
González P; Marín C; Rodríguez-González I; Hitos AB; Rosales MJ; Reina M; Díaz JG; González-Coloma A; Sánchez-Moreno M
Int J Antimicrob Agents; 2005 Feb; 25(2):136-41. PubMed ID: 15664483
[TBL] [Abstract][Full Text] [Related]
52. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection.
Aranha FC; Ribeiro U; Basse P; Corbett CE; Laurenti MD
Scand J Immunol; 2005 Oct; 62(4):334-41. PubMed ID: 16253120
[TBL] [Abstract][Full Text] [Related]
53. Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.
Llanos-Cuentas A; Tulliano G; Araujo-Castillo R; Miranda-Verastegui C; Santamaria-Castrellon G; Ramirez L; Lazo M; De Doncker S; Boelaert M; Robays J; Dujardin JC; Arevalo J; Chappuis F
Clin Infect Dis; 2008 Jan; 46(2):223-31. PubMed ID: 18171254
[TBL] [Abstract][Full Text] [Related]
54. Phase transfer catalyzed synthesis of bis-quinolines: antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial evaluation.
Palit P; Paira P; Hazra A; Banerjee S; Gupta AD; Dastidar SG; Mondal NB
Eur J Med Chem; 2009 Feb; 44(2):845-53. PubMed ID: 18538452
[TBL] [Abstract][Full Text] [Related]
55. Local application of diminazene aceturate: an effective treatment for cutaneous leishmaniasis?
Lynen L; Van Damme W
Ann Soc Belg Med Trop; 1992 Mar; 72(1):13-9. PubMed ID: 1567264
[TBL] [Abstract][Full Text] [Related]
56. Topical effectiveness of different concentrations of nanosilver solution on Leishmania major lesions in Balb/c mice.
Nilforoushzadeh MA; Shirani-Bidabadi LA; Zolfaghari-Baghbaderani A; Jafari R; Heidari-Beni M; Siadat AH; Ghahraman-Tabrizi M
J Vector Borne Dis; 2012 Dec; 49(4):249-53. PubMed ID: 23428525
[TBL] [Abstract][Full Text] [Related]
57. Comparison of the effect of drugs on Babesia in vitro and in vivo.
Irvin AD; Young ER
Res Vet Sci; 1978 Sep; 25(2):211-4. PubMed ID: 725337
[TBL] [Abstract][Full Text] [Related]
58. Encapsulation in lipid-core nanocapsules improves topical treatment with the potent antileishmanial compound CH8.
Escrivani DO; Lopes MV; Poletto F; Ferrarini SR; Sousa-Batista AJ; Steel PG; Guterres SS; Pohlmann AR; Rossi-Bergmann B
Nanomedicine; 2020 Feb; 24():102121. PubMed ID: 31672601
[TBL] [Abstract][Full Text] [Related]
59.
Rodriguez F; John SF; Iniguez E; Montalvo S; Michael K; White L; Liang D; Olaleye OA; Maldonado RA
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179532
[No Abstract] [Full Text] [Related]
60. In vitro effect of diamidines on intracellular polyamines of Acanthamoeba polyphaga.
Ogbunude PO; Asiri SA
Drugs Exp Clin Res; 2001; 27(4):127-33. PubMed ID: 11822222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
